Singapore will add the HPV9 vaccine to its national immunisation schedules from 1 January 2027, giving eligible Singaporean and permanent resident females aged 9 to 26 broader protection against cervical cancer, the Ministry of Health said.
The nine-valent vaccine, marketed as Gardasil 9, expands coverage compared with earlier HPV programmes. MOH said vaccination is recommended for females in the 9–26 band for prevention of HPV-related cancers.
Subsidies and MediSave
From the start date, eligible Singaporean children will receive full subsidies for HPV9 at Community Health Assist Scheme GP clinics and polyclinics. Eligible Singaporean adults can tap means-tested subsidies of up to 75 per cent at the same settings, while eligible permanent residents receive subsidies at polyclinics.
MediSave will cover recommended doses up to chronic and preventive care limits of S$700 or S$1,000, depending on the patient’s account rules. Subsidies will not apply to extra doses for individuals who already completed the recommended course with another formulation.
Booking and primary care load
MOH directed residents to book through vaccine.gov.sg or polyclinic appointment systems. Healthier SG enrollees are encouraged to schedule with their regular GP to keep preventive care on one record.
Clinics are already managing higher haze-related visits; adding a major vaccine rollout in January will test appointment capacity unless spread over school holidays. PHPC networks have experience from COVID and flu drives, but HPV counselling takes longer per patient.
Why the lead time
Announcing in October gives schools and parents time to plan for Primary 5 and Secondary 1 cohorts. MOH also updated the subsidised vaccine list documentation so insurers and employers can align corporate panels.
Women above 26 may still purchase HPV9 privately; the policy focus is on catching adolescents early. MOH did not change screening intervals for Pap smears — vaccination complements, not replaces, screening.
Public health stakes
Cervical cancer remains preventable with combined vaccination and screening. Singapore’s move to HPV9 matches regional upgrades as more countries switch from quadrivalent shots.
Households should check eligibility letters and CHAS status before January to avoid paying full price at the counter. The policy is months away, but clinic registration lists are already open on vaccine.gov.sg for other shots — a useful dry run for the HPV9 queue.
School health programmes
MOE school clinics will align HPV education modules before the January start date. Parents of Primary 6 girls will receive letters explaining how HPV9 differs from the two-valent shots offered to earlier cohorts.
Private obstetricians may continue offering HPV9 before 2027 at full price for patients who do not want to wait; MOH said completion of an earlier course does not qualify for subsidised top-up doses.